Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ATA3219 |
Synonyms | |
Therapy Description |
ATA3219 comprises allogeneic Epstein-Barr Virus (EBV)-targeted T-cells engineered to express a chimeric antigen receptor (CAR) targeting CD19, which potentially induce killing of CD19-expressing tumor cells and decrease tumor growth (Blood (2020) 136 (Supplement 1): 9). |